Laurie Connolly, OT | |
100 S I St, Ste 205, Aberdeen, WA 98520-6502 | |
(360) 532-1707 | |
(360) 532-1703 |
Full Name | Laurie Connolly |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 100 S I St, Aberdeen, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104858372 | NPI | - | NPPES |
7681679 | Medicaid | WA | |
GAB34664 | Other | WA | MEDICARE PTAN |
0167363 | Other | WA | L & I |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | OT00001109 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laurie Connolly, OT 100 S I St, Ste 205, Aberdeen, WA 98520-6502 Ph: (360) 532-1707 | Laurie Connolly, OT 100 S I St, Ste 205, Aberdeen, WA 98520-6502 Ph: (360) 532-1707 |
News Archive
Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced the results of Cubist's initial tender offer to purchase all of the outstanding shares of common stock of Adolor.
Inflammatory bowel disease (IBD) afflicts 1.6 million people in the United States, causing abdominal pain, diarrhea, constipation, rectal bleeding and other potentially debilitating symptoms.
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant cancers.
In a step towards a possible treatment for Huntington's disease, scientists at Albert Einstein College of Medicine of Yeshiva University have shown for the first time that the accumulation of a mutated protein may explain damaging cellular behavior in Huntington's disease. Their research is described in the April 11 online edition of Nature Neuroscience.
› Verified 4 days ago